Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.Bossi A, Foulon S, Maldonado X, et al. Lancet. 2024 Nov 23;404(10467):2065-2076. doi: 10.1016/S0140-67…